Yangzijiang, a global leader in shipbuilding and a component stock of the Straits Times Index, has entered into separate agreements to issue S$50 million of Unsecured Convertible Bonds to EDBI and Alexandrian Worldwide Incorporated.
Strategic Growth Programme (SGP)
Homegrown Mooring Solutions Provider, Mooreast Holdings Ltd., to Raise Total Gross Proceeds of S$8.5M from SGX Catalist IPO Offering of 800,000 Offer Shares at S$0.22 each and Placement of 38,050,000 Placement Shares at S$0.22 each Mooreast has received pre-IPO funding from Singapore-based global investor EDBI IPO Proceeds to fund Mooreast’s growth strategies to become a …
Esco Lifesciences starts operations at the world’s first contract manufacturing facility for cell cultured meat in Singapore
SINGAPORE, May 26, 2021 – Esco Lifesciences (“Esco”, the “Company”) announced today the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Novo Holdings A/S, with participation from new investors including China Investment Corporation, Singapore-based global investor EDBI, a reputable, long-term institutional investor, and other sophisticated investors.